Legend Biotech (LEGN) Debt Ratio: 2020-2025
Historic Debt Ratio for Legend Biotech (LEGN) over the last 4 years, with Sep 2025 value amounting to 0.10.
- Legend Biotech's Debt Ratio fell 41.26% to 0.10 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.10, marking a year-over-year decrease of 41.26%. This contributed to the annual value of 0.18 for FY2024, which is 18.50% up from last year.
- Per Legend Biotech's latest filing, its Debt Ratio stood at 0.10 for Q3 2025, which was down 45.33% from 0.18 recorded in Q2 2025.
- In the past 5 years, Legend Biotech's Debt Ratio registered a high of 0.22 during Q1 2023, and its lowest value of 0.03 during Q2 2021.
- For the 3-year period, Legend Biotech's Debt Ratio averaged around 0.16, with its median value being 0.16 (2024).
- Its Debt Ratio has fluctuated over the past 5 years, first surged by 1,979.82% in 2021, then plummeted by 41.26% in 2025.
- Legend Biotech's Debt Ratio (Quarterly) stood at 0.11 in 2021, then skyrocketed by 83.94% to 0.20 in 2022, then fell by 23.11% to 0.15 in 2023, then climbed by 18.50% to 0.18 in 2024, then slumped by 41.26% to 0.10 in 2025.
- Its Debt Ratio stands at 0.10 for Q3 2025, versus 0.18 for Q2 2025 and 0.19 for Q1 2025.